Xiangyu Medical Co. Ltd. A Market Cap ($945.65 Million)
Market Cap & Net Worth: Xiangyu Medical Co. Ltd. A (688626)
Xiangyu Medical Co. Ltd. A market cap. Xiangyu Medical Co. Ltd. A (SHG:688626) has a market capitalization of $945.65 Million (CN¥6.46 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #8821 globally and #2091 in its home market, demonstrating a -1.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xiangyu Medical Co. Ltd. A's stock price CN¥40.39 by its total outstanding shares 160000000 (160.00 Million). Also see 688626 cash flow metrics for how efficiently the company converts equity into cash flow.
Xiangyu Medical Co. Ltd. A Market Cap History (2021–2026)
Xiangyu Medical Co. Ltd. A market cap history from 2021 to 2026. Data shows change from $1.29 Billion to $945.65 Million (-1.17% CAGR). Check Xiangyu Medical Co. Ltd. A share price for real-time trading data and today's change.
Xiangyu Medical Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xiangyu Medical Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Xiangyu Medical Co. Ltd. A net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.93x
Xiangyu Medical Co. Ltd. A's market cap is 0.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.68x
Xiangyu Medical Co. Ltd. A's market cap is 6.68 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.29 Billion | $523.50 Million | $201.90 Million | 2.46x | 6.38x |
| 2022 | $730.12 Million | $488.53 Million | $125.47 Million | 1.49x | 5.82x |
| 2023 | $1.23 Billion | $744.81 Million | $227.14 Million | 1.65x | 5.40x |
| 2024 | $688.11 Million | $743.53 Million | $102.94 Million | 0.93x | 6.68x |
Competitor Companies of 688626 by Market Capitalization
Companies near Xiangyu Medical Co. Ltd. A in the global market cap rankings as of November 9, 2026. Also see Xiangyu Medical Co. Ltd. A total assets for a full breakdown of the balance sheet.
Key companies related to Xiangyu Medical Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Xiangyu Medical Co. Ltd. A (2021–2026)
Market capitalization of Xiangyu Medical Co. Ltd. A from 2021 to today. Between 2021 and today, Xiangyu Medical Co. Ltd. A's market cap moved from $1.29 Billion to $ 945.65 Million, with a yearly change of -1.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥945.65 Million | -33.24% |
| 2025 | CN¥1.42 Billion | +105.85% |
| 2024 | CN¥688.11 Million | -43.93% |
| 2023 | CN¥1.23 Billion | +68.10% |
| 2022 | CN¥730.12 Million | -43.35% |
| 2021 | CN¥1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Xiangyu Medical Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $945.65 Million USD |
| MoneyControl | $945.65 Million USD |
| MarketWatch | $945.65 Million USD |
| marketcap.company | $945.65 Million USD |
| Reuters | $945.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xiangyu Medical Co. Ltd. A
Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment… Read more